Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors. FDA decision on ...

FDA Granted Regulatory Clearance for XSenseTM Cryoablation System with CryoProbes: The next-generation XSenseTM system is cleared for the same indications that our flagship ProSense® system is ...

FDA Granted Regulatory Clearance for XSense™ Cryoablation System with CryoProbes: The next-generation XSense™ system is cleared for the same indications that our flagship ProSense® system is ...

IceCure Medical’s next-generation cryoablation technology to receive European patent: Caesarea, Israel Monday, January 6, 2025, 13:00 Hrs [IST] IceCure Medical Ltd., a developer ...

IceCure Medical (Nasdaq:ICCM) announced today that it received an intention to grant notice from the European Patent Office.

Adagio Medical has also initiated a pivotal study for its VT Cryoablation System, aiming for FDA premarket approval, and launched its vCLAS™ catheter and ultra-low temperature cryoablation ...

Adagio Medical has also initiated a pivotal study for its VT Cryoablation System, aiming for FDA premarket approval, and launched its vCLAS™ catheter and ultra-low temperature cryoablation system in ...

Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

XSense™ system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure "We are experiencing increased ...